SCA2 is known to show nigral atrophy and motor neuron loss; that is, the clinical manifestations of parkinsonism and motor neuron disease are within the spectrum of SCA2 pathology [39]–[41]. The gene discussed is ATXN2; the disease is Parkinson disease.